PARSIPPANY, N.J.— GlaxoSmithKline's diet pill, alli, is now back in most U.S. stores. Glaxo's innovation center for consumer products, in Parsippany, New Jersey, says the product package was redesigned to make tampering easier to spot. Before shipping alli, known chemically as orlistat, to retail stores, Glaxo launched it in mid-February through Drugstore.com and...» Read More
Onyx Pharmaceuticals CEO Dr. Anthony Coles discusses his company's thyroid cancer drug and its blood cancer drug and its partnership with Bayer.
NPS Pharmaceuticals CEO Dr. Francois Nader discusses the approval of its short bowel syndrome drug Gattex, and what's next for the company.
The latest batch of retail sales reports shed light on who the retail winners are right now.
The American Psychiatric Association now says it's okay to use antidepressants for someone who is grieving over a recently lost loved one. Beverly Hills Psychiatrist Dr. Carole Lieberman, offers insight.
The Supreme Court is taking on the "pay for delay" method used by big pharmaceutical companies, and pilots at American Airlines voted to ratify a new contract, reports CNBC's Brian Shactman.
CNBC's Jane Wells reports Washington's new state law that makes it legal to smoke pot, is more complicated than it sounds, and Allen St. Pierre, NORML executive director, weighs in on the financial benefits of reforming marijuana laws.
Some 150 workers at TriHealth, a Cincinnati-based health care company are unemployed today because they refused to get a free, company-sponsored flu shot. Michael Cannon, Cato Institute, thinks the company has a right to make this decision, while Barbara Fisher, National Vaccine Information Center, thinks this a violation of the workers' informed consent rights.
Colorado and Washington made history on Tuesday becoming the first states to legalize the recreational use of marijuana. Janine Turner, Constituting America founder & co-chair, says "this is really disappointing, and stealing the promise of the future of America."
A new study out today in The New England Journal of Medicine finds statin use reduces the risk of death from cancer. Dr. Lori Mosca of New York Presbyterian Hospital and Columbia University Medical Center, offers insight on the drug and its side effects.
The marijuana business is worth more than $300 billion worldwide, with CNBC's Brian Shactman & Brian Vicente, Campaign to Regulate Marijuana Like Alcohol.
NPS Pharmaceuticals president & CEO Dr. Francois Nader, discusses strategies his company uses to finding value for shareholders, and appealing to the FDA.
Why vitamin stocks are moving higher, with CNBC's Seema Mody.
NBC's Tom Costello reports on the outbreak of meningitis tied to a contaminated drug, saying as many as 13,000 people may have received one of the contaminated steroids.
Pharmaceuticals continue to be an attractive sector for earnings and dividend growth, and CNBC's Seema Mody reports on how companies like Pfizer are faring.
Medical experts convening at the American Neurology Association meeting to evaluate phase 3 Alzheimer's data on a drug from Eli Lilly. CNBC's Seema Mody reports.
If Amendment 64, which legalizes Marijuana and regulates it like alcohol, passes in Colorado this November, the state could see $64 million more in taxes, reports CNBC's Brian Shactman.
A provision of the Affordable Care Act squeezes premiums that drugmakers collect from the government has yielded savings of $687 million in the first six months of 2012.
The "Mad Money" host gets poetic and gives investors a glimpse of how the global economy might be seen through Charles Dickens' eyes.
With the weight loss market heating up, stocks like Arena Pharmaceuticals may be spelling out a big rally for the drug retail space.
Last week, Celgene announced it was pulling its Revlimid application in Europe, and Mad Money host Jim Cramer explains why he thinks investors should buy into the stock now.